← Leaderboards
Peter S Distefano
Zebra Biologics, Inc.
$334,595
Attributed
$823,544
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $308.7K · FY2019–21$500K$375K$250K$125K$0
'19
'20
'21
Funding mix
By agency
NIH$823,544 · 3
By mechanism
R41$823,544 · 3
Top collaborators
- Alexander I. Agoulnik1 shared
- Irina Agoulnik1 shared
- Patrice E. Fort1 shared
- Steven H Green1 shared
- Ronald Lindsay1 shared
Others in their field
Other Emerging Leaders on “Efficacy Study”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beth Baseler · Leidos Biomedical Research, Inc.$75,287,834
- Yunda Huang · Fred Hutchinson Cancer Center$72,814,726
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Julie Ake · National Institute Of Allergy And Infectious Diseases$50,742,120
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$42,989,272
Research focus
Efficacy StudyMedicalSmall Business Technology Transfer ResearchZebraApplications GrantsBiologicalProteinsRodent ModelTechnologyAgonistClinical TrialsAntibodiesAntibody EngineeringResponseAdultGrowth FactorFoundationsFrequenciesInjectionsDoseBaseDrug CandidateCommercializationComorbidity